Minimal Residual Disease Testing Infrastructure in Multiple Myeloma: Guidance for Clinical Trial and Routine Practice Use in Canada.

Journal

Clin Lymphoma Myeloma Leuk, 2025

Authors

Mian HS, Visram A, Shih SC, Trudel S, Hay AE, LeBlanc R, Sebag M, Kaedbey R, Stakiw J, Sandhu I, Phua CW, Kuruvilla PG, Othman I, Quest G, McMullen D, Colasurdo G, Kotb R, Venner CP

Learn More

BC Cancer Foundation is the fundraising partner of BC Cancer, which includes BC Cancer Research. Together with our donors, we are changing cancer outcomes for British Columbians by funding innovative research and personalized treatment and care.

Donate Today

Minimal Residual Disease Testing Infrastructure in Multiple Myeloma: Guidance for Clinical Trial and Routine Practice Use in Canada.

BC Cancer Research

Office of Research Administration

Population Health Sciences

Genome Sciences Centre

Terry Fox Laboratory

Molecular Oncology

Integrative Oncology

Lymphoid Cancer Research

Experimental Therapeutics

Clinical Research

Deeley Research Centre